Loading... Please wait... Loading... Please wait...
| Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 05/15/2024 | SABBY MANAGEMENT, LLC | 361,728 | $131,669 | -29.34% | 4.54% |
| 05/15/2024 | ARMISTICE CAPITAL, LLC | 266,968 | $97,176 | 29.62% | 3.35% |
| 05/13/2024 | RENAISSANCE TECHNOLOGIES LLC | 28,300 | $10,000 | -27.25% | 0.35% |
| 05/15/2024 | TWO SIGMA SECURITIES, LLC | 15,423 | $5,614 | 19.61% | 0.19% |
| 05/15/2024 | CITADEL ADVISORS LLC | 12,725 | $4,479 | -62.58% | 0.16% |
| 04/23/2024 | BFSG, LLC | 200 | $73 | 100.00% | 0.00% |
| 05/14/2024 | QUBE RESEARCH & TECHNOLOGIES LTD | 200 | $70 | 0.00% | 0.00% |
| 05/15/2024 | BANK OF AMERICA CORP /DE/ | 100 | $36 | 0.00% | 0.00% |
| 04/12/2024 | ADVISORNET FINANCIAL, INC | 80 | $29 | 100.00% | 0.00% |
| 05/13/2024 | UBS GROUP AG | 41 | $15 | 100.00% | 0.00% |
| 05/10/2024 | ADVISOR GROUP HOLDINGS, INC. | 41 | $13 | 0.00% | 0.00% |
| 05/07/2024 | ALLSQUARE WEALTH MANAGEMENT LLC | 21 | $8 | 0.00% | 0.00% |
| 05/15/2024 | 19 | $7 | 100.00% | 0.00% | |
| 05/13/2024 | NATIONAL BANK OF CANADA /FI/ | 12 | $3 | 0.00% | 0.00% |
| 04/23/2024 | GLOBAL RETIREMENT PARTNERS, LLC | 6 | $2 | 0.00% | 0.00% |
| 05/14/2024 | TORONTO DOMINION BANK | 2 | $1 | 0.00% | 0.00% |
| 05/06/2024 | ADVISORY SERVICES NETWORK, LLC | 0 | $0 | -100.00% | 0.00% |
| 05/10/2024 | TD WATERHOUSE CANADA INC. | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 18 institutional investors and hedge funds held shares of InMed Pharmaceuticals Inc.. The most heavily invested institutionals were:
SABBY MANAGEMENT, LLC: 361,728
ARMISTICE CAPITAL, LLC: 266,968
RENAISSANCE TECHNOLOGIES LLC: 28,300
TWO SIGMA SECURITIES, LLC: 15,423
CITADEL ADVISORS LLC: 12,725
BFSG, LLC: 200
A. 8.60% of InMed Pharmaceuticals Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 719,856 shares in the last 24 months. This purchase volume represents approximately $178,380 in transactions.
